These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 31059014)

  • 1. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
    Qiu G; Ma D; Li F; Sun D; Zeng Z
    Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis.
    Lu M; Qin X; Zhou Y; Li G; Liu Z; Geng X; Yue H
    Cell Death Dis; 2021 Jan; 12(1):72. PubMed ID: 33436545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth.
    Li Y; Cai Q; Li W; Feng F; Yang L
    Biochem Biophys Res Commun; 2018 Oct; 504(4):654-659. PubMed ID: 30205958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion.
    Li Z; Li J; Ji D; Leng K; Xu Y; Huang L; Jiang X; Cui Y
    Gene; 2018 Mar; 645():131-136. PubMed ID: 29246536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
    Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
    Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo.
    Yao Y; Sun Y; Jiang Y; Qu L; Xu Y
    Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
    Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
    Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA CCAT1 as the unfavorable prognostic biomarker for cholangiocarcinoma.
    Jiang XM; Li ZL; Li JL; Zheng WY; Li XH; Cui YF; Sun DJ
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1242-1247. PubMed ID: 28387907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
    Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Sungkhamanon S; Saya H; Loilome W
    J Transl Med; 2020 Feb; 18(1):64. PubMed ID: 32039729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
    Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
    Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
    Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding-RNA component of mitochondrial RNA processing endoribonuclease is involved in the progression of cholangiocarcinoma by regulating microRNA-217.
    Tang L; Wang Y; Wang H; Xu B; Ji H; Xu G; Ge X; Li Q; Miao L
    Cancer Sci; 2019 Jul; 110(7):2166-2179. PubMed ID: 31111617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway.
    Yu J; Zhang B; Zhang H; Qi Y; Wang Y; Wang W; Wang Y; Wang Y
    Biochem Biophys Res Commun; 2019 Apr; 512(2):150-155. PubMed ID: 30876691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma.
    Angenard G; Merdrignac A; Louis C; Edeline J; Coulouarn C
    Dig Liver Dis; 2019 Sep; 51(9):1337-1343. PubMed ID: 31040073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.
    Xu Y; Wang Z; Jiang X; Cui Y
    Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes.
    Han BW; Ye H; Wei PP; He B; Han C; Chen ZH; Chen YQ; Wang WT
    BMC Genomics; 2018 Oct; 19(1):735. PubMed ID: 30305026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA LINC01296 promotes tumor growth and progression by sponging miR-5095 in human cholangiocarcinoma.
    Zhang D; Li H; Xie J; Jiang D; Cao L; Yang X; Xue P; Jiang X
    Int J Oncol; 2018 Jun; 52(6):1777-1786. PubMed ID: 29620172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
    Wang X; Hu KB; Zhang YQ; Yang CJ; Yao HH
    Cancer Biomark; 2018; 23(4):549-559. PubMed ID: 30452401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8.
    Jiang X; Li J; Wang W; Hu Z; Guan C; Zhao Y; Li W; Cui Y
    Aging (Albany NY); 2020 Jan; 12(2):1237-1255. PubMed ID: 31978895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.